Pular para o conteúdo principal
Ranking Invest

IQV - IQVIA Holdings Inc.

Segmento: HealthcareIQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Análise Ranking Invest

Valor de Mercado
$ 45.99 Bi
IVR
0.20Índice proprietário de comparação relativa: 0,20.
IVR2
0.10Leitura proprietária complementar: 10%.
MLL
0.10Leitura proprietária complementar: 10%.
Último Balanço Atualizado: 3T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 6.09 Bi

Dívida Líquida

$ 13.89 Bi

L4T

$ 1.39 Bi

MM4T

8.27%

Indicadores Básicos

ROE

22.73%

Índices de Previsibilidade

Receita Líquida

A0.02

Lucro

B0.17

Margem

B0.16

Índices de Tendência

Receita Líquida

A10.80

Lucro

C4.11

Margem

C1.95

Índices de Endividamento

DIV/PAT

2.28

DIV/L4T

10.03

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.